Nuvalent, Inc.

Please be aware of fraudulent job postings and individuals falsely claiming to be employees of Nuvalent. These scams often request sensitive personal or financial information. ✅ Legitimate Nuvalent emails come only from @nuvalent.com ✅ System response emails from our Greenhouse applicant tracking system come from a no-reply@greenhouse.io email address ✅ All job offers follow a formal application + interview process ❌ We never request personal/financial info via email If you’ve been contacted by someone misrepresenting Nuvalent, please report it to jobfraud@nuvalent.com and/or 857-357-7000. Thank you for staying vigilant!

At Nuvalent, collaboration is at the heart of everything we do, no matter the location and time zone. That’s why we’re intentional about creating opportunities to come together in person. We value our annual summer outing as a chance to strengthen the connections that power both our work and our culture. Because strong teamwork thrives alongside intentional rest, we’re proud to support the #NuCrew both on and off the clock. With our summer shutdown ahead, we’re making time to pause, recharge, and return ready to keep building together!

This morning, we reported our Q2 2025 financial results alongside recent pipeline & business achievements and anticipated milestones:             ▶️ Initiated rolling NDA submission for zidesamtinib for TKI pre-treated patients with advanced ROS1-positive NSCLC, with target completion in the 3Q of 2025 🔬 Initiated ALKAZAR Phase 3 randomized, controlled trial of neladalkib for front-line ALK-positive NSCLC 📊 Topline pivotal data for neladalkib for TKI pre-treated patients with advanced ALK-positive NSCLC expected by year-end 2025 📊 Preliminary data for neladalkib in patients with ALK-positive solid tumors beyond NSCLC to be presented at the ESMO Congress 2025 In addition, we’re proud to recognize the promotion of Jason Waters to SVP, Commercial, in recognition of his contributions towards our vision of becoming a fully integrated, commercial-stage biopharmaceutical company. 🌟 Learn more: https://lnkd.in/eqnZTWae #NSCLC #Biotech #Oncology

This #WorldLungCancerDay, we’re inspired by the strength, resilience, and voices of the #LungCancer community. At the recent ALK Positive Inc. Summit, we had the privilege of hearing directly from patients and caregivers, a reminder of why we do what we do. Their stories underscore the urgent need for continued research, personalized care, and new therapy options. At Nuvalent, we remain committed to developing #PreciselyTargetedTherapies for people living with #cancer. Together, we move forward with purpose, with compassion, and with patients at the center. #ALKPositive #TheROS1ders #LungCancerAwareness #Oncology

A warm welcome to Chad, Caitlin, Zi, Shayne, and Juli, the newest trailblazers joining our #NuCrew! Each one brings a unique mix of passion, curiosity, and purpose, perfectly aligned with our mission to create meaningful change for patients. We're thrilled to have them on this journey with us.

✅ Milestone Alert: ALKAZAR Phase 3 Trial Initiated Today we announced the dosing of the first patient in ALKAZAR—our global, pivotal Phase 3 trial evaluating neladalkib in TKI-naïve patients with ALK+ #NSCLC. The initiation of this head-to-head study against alectinib represents a significant milestone for our portfolio of #PreciselyTargetedTherapies and marks an important step toward our goal of bringing neladalkib to the front line of ALK+ lung cancer care. Read the full update: https://lnkd.in/eXfrwkK5 #ALKPositive #ClinicalTrials #Oncology #Biotech

We’re heading to sunny San Diego as a proud sponsor of this year’s ALK Positive Inc. Summit! We look forward to connecting with patients, caregivers, and healthcare experts as we explore the latest in #ALK+ NSCLC research and cancer care. Register to join virtually: https://lnkd.in/ghqZTsQj #StrongerTogether #ALKSummit25 #LungCancer

🎉Milestone Alert: The #NuCrew is 200 strong! 🚀 From our first hire to our 200th team member, we’re grateful for the collaboration, passion, and talent that every individual brings to Nuvalent. To our incredible team, thank you for your belief in our mission. You've helped shape who we are today: a passionate, patient-focused, and purpose-driven organization. We’re excited for all we’ll continue to achieve together.

Driven by purpose and fueled by collaboration (and good food!), the #NuCrew is united by our shared goal of making a meaningful difference for patients. Check out our latest roles in Clinical, Quality, Pharmaceutical Development, and more: https://lnkd.in/g2yuEE8M #careers #biotech

We’re proud to support the DAVA Oncology 4th Summit on Thoracic Malignancies, which brings together global experts in #LungCancer research and care. We look forward to engaging discussions, expert insights, and new approaches shaping the future of thoracic oncology.